Publicacions en col·laboració amb investigadors/es de Hospital for Sick Children (62)

2024

  1. A road map for the treatment of pediatric diffuse midline glioma

    Cancer Cell

  2. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  3. Chemotherapy in pediatric low-grade gliomas (PLGG)

    Child's Nervous System, Vol. 40, Núm. 10, pp. 3229-3239

  4. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study

    The Lancet Oncology, Vol. 25, Núm. 5, pp. 668-682

  5. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  6. Development and external validation of the 'Global Surgical-Site Infection' (GloSSI) predictive model in adult patients undergoing gastrointestinal surgery

    British Journal of Surgery, Vol. 111, Núm. 6

  7. Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA

    Hepatology (Baltimore, Md.), Vol. 79, Núm. 6, pp. 1279-1292

  8. Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngioma

    Frontiers in Oncology, Vol. 14

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Neurocognitive outcomes in pediatric brain tumors after treatment with proton versus photon radiation: a systematic review and meta-analysis

    World Journal of Pediatrics, Vol. 19, Núm. 8, pp. 727-740

  3. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908

    Neuro-Oncology, Vol. 25, Núm. 8, pp. 1530-1545

  4. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation Sparing Approaches: An International Cohort Study

    Journal of Clinical Oncology, Vol. 41, Núm. 10, pp. 1921-1932

  5. Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600 Mutant Pediatric High-Grade Glioma

    Journal of Clinical Oncology, Vol. 41, Núm. 33, pp. 5174-5183

2022

  1. Clinical and molecular characteristics of pediatric low-grade glioma complicated with ventriculo-peritoneal shunt related ascites

    Journal of Neuro-Oncology, Vol. 157, Núm. 1, pp. 147-156

  2. Prognostic factors for patients with relapsed central nervous system nongerminomatous germ cell tumors

    Pediatric Blood and Cancer, Vol. 69, Núm. 1

  3. V̇/Q̇ Mismatch: A Novel Target for COPD Treatment

    Chest, Vol. 162, Núm. 5, pp. 1030-1047

2021

  1. Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study

    The Lancet Child and Adolescent Health, Vol. 5, Núm. 11, pp. 800-813

  2. Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C

    Journal of Clinical Endocrinology and Metabolism, Vol. 106, Núm. 2, pp. E660-E674

  3. Evaluation of the pediatric neuro-oncology resources available in Chile

    JCO Global Oncology, Vol. 7, pp. 425-434

  4. Follow-up evaluation of a web-based pediatric brain tumor board in Latin America

    Pediatric Blood and Cancer, Vol. 68, Núm. 9